tbuckley/cabot-search huggingface dataset:
Differences in Treatment Decision-Making in Frontline Management of Lower-Risk Myelodysplastic Syndromes between Academic and Community Practice Settings: Results from a Nationwide Survey
Authors: Mikkael A. Sekeres, Sangeetha Venugopal, Namrata S. Chandhok, Justin M. Watts, Terrence Bradley, Justin Taylor, David Sallman, Zhuoer Xie, Eric Padron, Shelby Sullivan, Emily Zyborowicz, Jeffrey Carter, Cherilyn Heggen, Lindsay Gurska, Rami S. Komrokji
Journal: Blood (2024)
Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)
Authors: Donna E Reece, Giovanni Piza Rodriguez, Mariela A Pantoja, Eshetu G Atenafu, Darrell White, Irwindeep Sandhu, Julie Stakiw, Michael Sebag, Terrance Comeau, Kevin Song, Jean Roy, Martha L Louzada, Arleigh McCurdy, Vishal Kukreti, Suzanne Trudel, Anca Prica, Rodger E Tiedemann, Christine I Chen
Journal: Blood (2024)
Sentiment Analysis Applied to Digital Conversations Among Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Receiving Rituximab and/or Blood Transfusion
Authors: Caroline Piatek, Louis Jackson, Caroline Brethenoux, Alyssa DeLuca, Zia Choudhry, Jacqueline Pesa, Alex Lorenzo, Patrick Furey, Laura Gonzalez Quijano, Rosario Alvarez, Julija Paskevicius, Nora Sandorfi
Journal: Blood (2024)
Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®
Authors: Allison M. Winter, Olivia Landever, Hiruni Mendries, Willem Van Heeckeren, Chieh-Lin Fu, Robert M. Dean, Taylor R. Brooks, Deepa Jagadeesh, Paolo F. Caimi, Brian T. Hill
Journal: Blood (2024)
Durability of Complete Responses in Patients from the ECHELON-3 Study
Authors: Christopher Yasenchak, Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Craig A. Portell, Francesco Zaja, Thorsten Zenz, Cecily Forsyth, Jin Seok Kim, Seok-Goo Cho, Jae-Yong Kwak, Hao-Yuan Wang, Herve Ghesquieres, Grzegorz S. Nowakowski, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Frank Stenner
Journal: Blood (2024)
CAR T-Cell Therapy for DLBCL with CNS Involvement: Overall Safe and Effective with Limited Efficacy in Patients with Leptomeningeal Disease
Authors: Efrat Luttwak, Giulio Cassanello, Samantha Brown, Sean M. Devlin, Brandon S. Imber, Andrew Ip, Lori A. Leslie, Noa Golan Accav, Ofrat Beyar-Katz, Magdalena Corona, Alejandro Luna De Abia, Alfredo Rivas-Delgado, Jennifer Kimberly Lue, Christian Grommes, Gunjan L. Shah, Jae H. Park, Miguel Angel Perales, Gilles Salles, Roni Shouval, Maria Lia Palomba, Michael Scordo
Journal: Blood (2024)
Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naïve Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada
Authors: Jens Panse, Juan Carlos Vallejo Llamas, Koo Wilson, Zalmai Hakimi, Barbara Czech, Brianne Kerr, Sam Williamson, Jade Garratt-Wheeldon, Yasmin Taylor, Niall Hatchell, Christopher Patriquin
Journal: Blood (2024)
Hematopoietic Stem Cell Transplantation for Marginal Zone Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Authors: Yasmina I.M. Serroukh, Mathilde Fekom, Irma Khvedelidze, Ben Carpenter, Herve Ghesquieres, Ludovic Gabellier, Jacques-Olivier Bay, Didier Blaise, Maurizio Musso, Patrice Chevallier, Edouard Forcade, Anne Huynh, Andy Peniket, Marek Trněný, Catherine Flynn, Shankara Paneesha, Andrew Clark, Charalampia Kyriakou, Anna Ossami Saidy, Bertram Glass, Luca Castagna, Silvia Montoto, Ali Bazarbachi
Journal: Blood (2024)
Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
Authors: Binod Dhakal, Michael Slade, Ravi Narra, Mostafa E. Mohamed, Othman S. Akhtar, Hima Bansal, Maria Jose Acevedo-Calado, Oren Pasvolsky, Mahmoud R. Gaballa, Melody R. Becnel, Donna M. Weber, Krina K. Patel, Sheeba K. Thomas, J Christine Ye, Frank Kuhr, Bamboo Dong, Shemeeakah Powell, Thai Bui, Meera Mohan, Marcelo C. Pasquini, Anita D'Souza, Halyna Knysh, Robert Z. Orlowski, Maher Albitar, Hans C. Lee
Journal: Blood (2024)
Efficacy and Safety of Teclistamab in Relapsed Refractory Multiple Myeloma: Long-Term Follow-up from a Real World Multi-Institutional Cohort
Authors: Metodi Balev, Nishi Shah, Mansi R. Shah, Anannya Patwari, Aniko Szabo, Anita D'Souza, Asis Shrestha, Binod Dhakal, Danny Luan, Dennis L Cooper, Frits van Rhee, Heloise Cheruvalath, Jorge Monge, Mark Forsberg, Maurizio Zangari, Sharmilan Thanendrarajan, Vineel Bhatlapenumarthi, Samer Al-Hadidi, Suzanne Lentzsch, Divaya Bhutani, Rajshekhar Chakraborty, Carolina Schinke, Meera Mohan
Journal: Blood (2024)
Clinical Characteristics and Outcomes of Aggressive Transformation in Splenic Marginal Zone Lymphoma: An International Study of 111 Patients
Authors: Ahmed Ludvigsen Al-Mashhadi, Mikkel Runason Simonsen, Elizabeth Smyth, Rose-Marie Amini, Bente Arboe, James R. Cerhan, Iman Chanchiri, Chan Y. Cheah, Jonathan Day, Toby A. Eyre, Anne Ortved Gang, Hervé Ghesquieres, Thomas M. Habermann, Eliza A. Hawkes, Steven R. Hwang, Ruxandra Irimia, Jennifer B Jørgensen, Arushi Khurana, Claire Maquet, Ng Layshe, Stephen S. Opat, Martin Bjerregård Pedersen, Christian Bjørn Poulsen, Alexandros Rampotas, Andreea Sima, Karin Ekstroem Smedby, Knut Smeland, Gita Thanarajasingam, Judith Trotman, Katharine Xing, Simon Østergaard, Diego Villa, Tarec Christoffer El-Galaly
Journal: Blood (2024)
Frailty and Outcomes after Bispecific T-Cell Engager Therapy for Patients with Relapsed/Refractory Multiple Myeloma
Authors: Benjamin O Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S Firestone, Eric M Jurgens, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Sridevi Rajeeve, David J. Chung, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Sergio Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi
Journal: Blood (2024)
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Authors: Tyler B. Sandahl, Jenna Puttkammer, Chelsee J. Jensen, Adrienne N. Nedved, Justine Wilson-Miller, Kristin Cole, Lucy Holmes, Allison Kosobud, Prashant Kapoor, Morie A. Gertz, David Dingli, Wilson I. Gonsalves, Shaji Kumar, Suzanne R Hayman, Taxiarchis Kourelis, Rahma M Warsame, Moritz Binder, Joselle Cook, Yi Lin, Jason Barreto
Journal: Blood (2024)
Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
Authors: Anup Kumar Trikannad, Sruthi Vellanki, Jim Zhongning Chen, Alan Baltz, Mamatha Gaddam, Ankur Varma, Muthu V. Kumaran, Cesar Giancarlo Gentille Sanchez
Journal: Blood (2024)
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies - a BMT Survivor Study (BMTSS)
Authors: Nora Balas, Joshua Richman, Wendy Landier, Sadeep Shrestha, Katia J Bruxvoort, Lindsey Hageman, Qingrui Meng, Elizabeth Ross, Alysia Bosworth, Hok Sreng Te, F. Lennie Wong, Ravi Bhatia, Stephen J. Forman, Saro Armenian, Daniel Weisdorf, Smita Bhatia
Journal: Blood (2024)
Role of Social Determinants of Health on Infection-Related Hospitalizations in Pediatric Hematopoietic Stem Cell Transplant Patients within the First 100 Days Post-Transplant in an Underserved State
Authors: Alexis Brantley, Nali Gillespie, Morgan Viviano, Leah Smith, Zhide Feng, Maria C. Velez-Yanguas, Zachary LeBlanc
Journal: Blood (2024)
Transcriptional Profiling Directs the Classification of Mixed Phenotype Acute Leukemias into AML, B-ALL or T-ALL
Authors: Roger Mulet-Lazaro, Aniko Sijs-Szabó, Remco Hoogenboezem, Stanley Van Herk, Patricia G. Hoogeveen, Francois Kavelaars, Anita Schelen, Willemijn van den Ancker, Arjan A. van de Loosdrecht, Berna Beverloo, Vincent H.J. Van Der Velden, Jan J. Cornelissen, Peter J. M. Valk, Anita W. Rijneveld, Mathijs Arnoud Sanders
Journal: Blood (2024)
Food Insecurity and Cardiovascular Risk Among Survivors of Pediatric Hematologic Malignancies
Authors: Rahela Aziz-Bose, Lucille Lokko, Morgan A. Paul, Colleen A. Kelly, Leanne Duhaney, Puja J. Umaretiya, Fang Fang Zhang, Lisa B. Kenney, Kira Bona
Journal: Blood (2024)
An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Authors: Nina Caculitan, GaYeon Kim, Ann Woolfrey, Luke P. Akard, Ah-Reum Jeong, Jack Khouri, Gunjan L. Shah, Pina M. Cardarelli
Journal: Blood (2024)
Of Seven Molecular Subtypes in MGUS the Low Bone Disease (LB) Subtype Exhibits Resistance to Multiple Myeloma Progression
Authors: Catherine Ma, Fumou Sun, Clyde Bailey, Hongwei Xu, Samer Al Hadidi, Carolina Schinke, Maurizio Zangari, Sharmilan Thanendrarajan, Frits van Rhee, John D Shaughnessy, Jr, Fenghuang Zhan
Journal: Blood (2024)
Impact of Conditioning Intensity on Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Patients with Acute Leukemia and Myelodysplastic Syndromes
Authors: Moazzam Shahzad, Muhammad Kashif Amin, Aqeeb Ur Rehman, Aleenah Mohsin, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Haitham Abdelhakim, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
Incremental Effectiveness of Iptacopan Compared with C5 Inhibitors in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Modelling Analysis
Authors: Shreyans Gandhi, Regis Peffault De Latour, Katharina Pannagl, Maria-Magdalena Balp, Anggie Wiyani, Cheryl Druchok, Paul Lebeau, Richard J. Kelly
Journal: Blood (2024)
Infection Risk and Efficacy of Anti-BCMA Bispecific Antibodies in Multiple Myeloma: A Real-World Propensity Score-Matched Study
Authors: Jeremie Zerbit, Guillemette Fouquet, Marion Detroit, Sylvain Choquet, Laurent Garderet, Olivier Hermine, Clarisse Cazelles, Laurent Frenzel, Mohamad Mohty, Zoe Van De Wyngaert, Harel Stephanie, Karim Belhadj Merzoug, Sabine Brechignac, Didier Bouscary, Cyrielle Rodier, Romain Winer, Mathis Collier, Marguerite Vignon
Journal: Blood (2024)
Clonal Dominance in Follicular Lymphoma: A Predictor of Poor Prognosis and Histological Transformation
Authors: Vincent Camus, Mathieu Viennot, Victor Bobée, Pierre-Julien Viailly, Elodie Bohers, Vinciane Rainville, Marie-Delphine Lanic, Elena-Liana Veresezan, Fanny Drieux, Emilie Leveque, Pascaline Etancelin, Dominique Penther, Hervé Tilly, Alexandra Zduniak, Philippe Ruminy, Fabrice Jardin
Journal: Blood (2024)
<i>Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study</i>
Authors: Serif Sungur, Yao Yao, Cameron Wellard, Eliza Chung, Susan Morgan, Denise Lee, Geoffrey Chong, Chan Y. Cheah, Tasneem Rizvi, Eliza A. Hawkes, Zoe K McQuilten, Erica M. Wood, Nada Hamad, Tasman Armytage, Anna M. Johnston
Journal: Blood (2024)
Large Scale Manufacturing of GMP Grade Cord Blood Derived Megakaryocytes for Chemotherapy Induced Thrombocytopenia
Authors: Hila Shaim, Mayela Carolina Mendt, Hani Lee, Bijender Kumar, Min Soon Cho, Alejandro Ramirez, Indreshpal Kaur, Torey Mallory, Arthur Aquino, Patrick Olivares, Cody Hensley, Kendall Friedman, Mecit Kaplan, Ana K. Nunez Cortes, Jeff Wilson, Jeremy Ramdial, Uday Popat, Vahid Afshar-Kharghan, Katayoun Rezvani, Elizabeth J. Shpall
Journal: Blood (2024)
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population
Authors: Zixun Yan, Dehui Zou, Wenbin Qian, Ying Lu, Yuhua Li, Dongmei Ji, Xiaojian Zhu, Heng Mei, Ping Li, Changju Qu, Lei Zhang, Keshu Zhou, Hongmei Jing, Ting Niu, Chunyan Ji, Lanfang Li, Hua Yang, Fei Li, Wei Wang, Kailin Xu, Jinghua Zhao, Depei Wu, Yu Hu, Weili Zhao
Journal: Blood (2024)
CAR-T Therapy Showdown: Comparative Efficacy and Safety of of Ide-Cel (Idecabtagene vicleucel) and Cilta-Cel (Ciltacabtagene Autoleucel) in Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Study
Authors: Amna Gul, Yumna Afaq, Talha Khan, Mahnoor Asghar Keen, Shayan Ahmad, Mahd Aftab Khan, Rida Hussain, Arslan Inayat, Danish Safi, Salahuddin Safi
Journal: Blood (2024)
Replication Stress Induces Hyper-Apobec Mutagenesis in Multiple Myeloma
Authors: Marios Papadimitriou, Marilena Tauro, Afsaneh Panahi, Bachisio Ziccheddu, Alexandra Maria Poos, Abdessamad Youssfi Alaoui, Dario Magaletti, Mark B. Meads, Kylee H Maclachlan, Marc S. Raab, Gareth Morgan, Saad Z. Usmani, Niels Weinhold, Ola Landgren, Kenneth H. Shain, Florian Kuchenbauer, Francesco Maura
Journal: Blood (2024)
Retrospective Cohort Analysis of Response and Survival of Children, Adolescents, and Young Adults (CAYA) with Relapsed and/or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoma (T-LL) Treated with Curative Intent: A TACL Consortium Study
Authors: Melinda G Pauly, Yueh-Yun Chi, Jemily Malvar, Roy Leong, Susan Colace, Nathan Gossai, Nobuko Hijiya, Chintan Parekh, Susan R Rheingold, Anupam Verma, Bill H Chang, Todd M Cooper, Andrew Doan, Yamilet Huerta, Kelly Elizabeth Faulk, Diane Hanna, Kenneth Matthew Heym, Mallorie M. Heneghan, Joel Kaplan, Luciano Dalla-Pozza, Seth E. Karol, Andrew E. Place, Jenna Rossoff, Eric S. Schafer, Tamra Slone, Michelle L. Hermiston, Maria Luisa Sulis
Journal: Blood (2024)
Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with Early Progression Following Induction with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd)
Authors: Lilly Gu, Nisha S. Joseph, Vikas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Sagar Lonial, Ajay K. Nooka, Jonathan L. Kaufman
Journal: Blood (2024)
Ropeginterferon Alfa-2b (ROPEG) and Peginterferon Alfa-2a (PEG) at Low Dose with Response-Based Titration (LDRT) Have Comparable Efficacy and Tolerability in Polycythemia Vera (PV)
Authors: Neville Lee, Katie Erdos, Aqib Abdul Rahman, Richard T. Silver, Joseph M. Scandura, Ghaith Abu-Zeinah
Journal: Blood (2024)
AL Amyloidosis: Understanding the Clinical Prodrome and Delays in Diagnosis
Authors: Nadine Abdallah, Jay R. Hydren, Mason S. Barnes, Andrew Wood, Sascha Alexander Tuchman, Jeffrey A. Zonder, Giada Bianchi, Heather J. Landau, Muhamed Baljevic, James E. Hoffman, Ana M. Sahagun Sanchez Aldana, Jorge Arturo Hurtado Martinez, Jennifer M. Ahlstrom, Morie A. Gertz
Journal: Blood (2024)
Long-Term Follow-up Analysis of Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma Patients from the GMMG Myeloma Registry Following the Randomized Phase III GMMG-HD6 Trial
Authors: Anne-Valérie Keller, Marina Hajiyianni, Eileen Kurre, Elias Karl Mai, Uta Bertsch, Axel Benner, Steffen Luntz, Marc-Steffen Raab, Britta Besemer, Christian Sebastian Michel, Roland Schroers, Roland Fenk, Hans Salwender, Igor Wolfgang Blau, Mathias Hänel, Christoph Mann, Hartmut Goldschmidt
Journal: Blood (2024)
Smoldering Multiple Myeloma in Latin America- Risk Stratification
Authors: Edvan De Queiroz Crusoe, Alana Von Glasenapp, Glaciano Ribeiro, Leila Perobelli, Paola Ochoa, Fernando Vieira Pericole, Sergio Lopresti, Jayr Schmidt Filho, Cesar Samanez, Guillermina Remaggi, Emanuella Souza, Eloisa Riva, Javiera PAZ Donoso Pineda, Pedro Manoel Marques Garibaldi, Milton A. F. Aranha, Roberto Pessoa Magalhaes Filho, Aline Ramirez Alvarado, Dorotea Beatriz Eugenia Fantl, Kenny Galvez, Dani Laks, Jose Ramiro Espinoza Zamora, Juliana Lima, Rodrigo Ezequiel Vallejo, Camila Peña, Vania Hungria
Journal: Blood (2024)
Daratumumab Versus Lenalidomide As Maintenance Therapy in Newly Diagnosed Multiple Myeloma - Interim Efficacy Results of a Randomized Clinical Trial
Authors: Sridevi Rajeeve, Andriy Derkach, Sean M. Devlin, Jeannen Santos, Anna Przemielewska, Tara Sood, Kylee H Maclachlan, Hamza Hashmi, Carlyn Rose Tan, Neha Korde, Malin Hultcrantz, Parastoo B Dahi, Alexander M. Lesokhin, Michael Scordo, David J. Chung, Heather J. Landau, Gunjan L. Shah, Ola Landgren, Sergio A. Giralt, Sham Mailankody, Saad Z. Usmani, Urvi A. Shah
Journal: Blood (2024)
Characterizing Environmental Adaption and Virulence of Gut Microbiome <i>Enterococcus Spp.</i> from Patients Receiving CD19-Targeted CAR-T Cell Therapy
Authors: Niklas Deschl, Viktoria Blumenberg, Maria-Luisa Schubert, Anita Schmitt, Michael Schmitt, Marion Subklewe, Christoph Stein-Thoeringer
Journal: Blood (2024)
Real-World Practice Patterns of Patient Management in the Peri-CAR T-Cell Therapy Setting for Patients with Mantle Cell Lymphoma: An International Survey on Behalf of the EBMT Lymphoma Working Party
Authors: Gloria Iacoboni, Pere Barba, Irma Khvedelidze, Maud Ngoya, Paolo Corradini, Pierre Sesques, Marion Subklewe, Maria Gomes Da Silva, Gilles Crochet, Jarosław Dybko, Izaskun Zeberio, Alejandro Martín García-Sancho, Tom van Meerten, Maeve O'Reilly, Bertram Glass, Ana Maria Sureda Balari, Peter Dreger, Olivier Hermine, Ali Bazarbachi
Journal: Blood (2024)
Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma
Authors: Yuma Nato, Kana Miyazaki, Ayumi Fujimoto, Senzo Taguchi, Naoko Asano, Jun Amaki, Wataru Munakata, Yuko Shirouchi, Nobuko Kubota, Takeshi Maeda, Jun Takizawa, Kimikazu Yakushijin, Rika Sakai, Hideyuki Nakazawa, Masahiro Takeuchi, Noriko Fukuhara, Yuri Miyazawa, Ryoji Tokiya, Tohru Murayama, Isao Tawara, Yasuo Ejima, Ritsuro Suzuki, Motoko Yamaguchi
Journal: Blood (2024)
Determination of MYD88 and CXCR4 Mutation for Clinical Detection and Their Significance in Waldenström Macroglobulinemia
Authors: Ying Yu, Yuting Yan, Xiong Wenjie, Jun Wang, Yao Yao, Yuxi Li, Tingyu Wang, Rui Lyu, Hao Sun, Qi Wang, Wei LIU, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Zhen Yu, Dehui Zou, Mu Hao, Zhi-jian Xiao, Jianxiang Wang, Lu-Gui Qiu, Shuhua Yi
Journal: Blood (2024)
IL-1RAP Is a Targetable Surface Antigen in Relapsed/Refractoy AML
Authors: Mohamad Sabbah, Morgane Fontaine, Kim Pacchiardi, Alexis Delabrière, Stephane De Botton, Catherine Lonchamp, Renaud Buffet, Laure Farnault, Jean-Baptiste Micol, Typhaine Dumas-Rivero, Emmanuel Raffoux, Lionel Ades, Nicolas Boissel, Juliette Lambert, Kevin-James Wattebled, Matthieu Duchmann, Karine Celli-Lebras, Alexandra Coelho, Hervé Dombret, Edouard De Dreuzy, Marina Deschamps, Christophe Ferrand, Jens Hasskarl, Richard Sainson, Raphael Itzykson
Journal: Blood (2024)
An Uniquely Designed Asymmetric Bispecific Antibody Against GPRC5D and CD3 (LBL-034) in Patients with Relapsed/Refractory Multiple Myeloma: A Phase I/II, First in Human, Open-Label, Multicenter, Dose Escalation/Expansion Study
Authors: Ling Qin, Yuping Zhong, Dongping Huang, Haitang Xie, Xin Du, Aijun Liao, Hongli Zhang, Shengli (Charles) Cai, Jin Lu
Journal: Blood (2024)
Strength to Endure: Superiority of MAC over RIC in Patients &amp;lt;65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis
Authors: Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, Fotios Michelis, Arjun D. Law, Wilson Lam, Dennis Dong Hwan Kim, Ivan Pasic, Igor Novitzky-Basso, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
Journal: Blood (2024)
Outcome of T-Cell/Histiocyte-Rich Large B-Cell Lymphoma in Denmark 2008-2022
Authors: Peter Brændstrup, Thomas Bech Mortensen, Tarec Christoffer El-Galaly, Michael Boe Møller, Judit Mészáros Joergensen, Christian Bjørn Poulsen, Peter de Nully Brown, Dennis Lund Hansen, Thomas Stauffer Larsen
Journal: Blood (2024)
Clinical Outcomes in Black Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 Monumental-1 Study
Authors: Carolina Schinke, Gareth Morgan, Luciano J. Costa, Natalie Callander, Don A. Stevens, Jesus G Berdeja, Brea Lipe, Sagar Lonial, Marie-Christiane Vekemans, Ravi Vij, Philippe Moreau, Paula Rodríguez-Otero, Anna Sureda Balari, Thomas Renaud, Jaszianne Tolbert, Bonnie W Lau, Brandi W Hilder, Tara J Masterson, Michela Campagna, Veronique Vreys, Christoph Heuck, Colleen Kane, Kathleen S Gray, Deeksha Vishwamitra, Indrajeet Singh, Joy Gong, Xiang Qin, Larysa Sanchez
Journal: Blood (2024)
Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation in a Spanish Multicenter Cohort on Behalf of Geth
Authors: Annalisa Paviglianiti, Estefanía Pérez López, Alejandro Avendaño Pita, Monica Baile Gonzalez, Candela Ceballos Bolaños, Itziar Oiartzabal Ormategui, Albert Esquirol, Irene García-Cadenas, Maria Queralt Salas, Sara Fernandez-Luis, Juan Dominguez Garcia, Inmaculada Heras, Alberto Mussetti, Lucia García Mañó, Tamara Torrado Chedas, Sara Villar, Alberto Lopez Garcia, Adolfo Jesús Sáez Marín, Ana Pilar Gonzalez, Maria Jesus Pascual
Journal: Blood (2024)
Idecabtagene Vicleucel (Ide-cel) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Front-Line Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up
Authors: Barry Paul, Madhav V. Dhodapkar, Melissa Alsina, Jesús G. Berdeja, Shambavi Richard, Ravi Vij, Xavier Leleu, Daniel N. Egan, P. Leif Bergsagel, Ran Reshef, Saad Z. Usmani, Anna Truppel-Hartmann, Debashree Basudhar, Ethan G. Thompson, Fan Wu, Laurie Eliason, Soyun Park, Sinhan Tran, Maria Chaudhry, David S. Siegel, Krina K. Patel
Journal: Blood (2024)
Single-Cell Transcriptomic Analysis Reveals Distinct Hematopoietic Landscapes and Immune Dysregulation in Der(1;7)(q10;p10) Myelodysplastic Syndromes
Authors: Hongyan Tong, Wei Wang, Yingwan Luo, Wei Lang, Wenbin Yang, Wenli Yang, Wenxia Li, Hua Huang
Journal: Blood (2024)
Dysregulation of Transposable Elements and Piwi-Interacting RNAs in Myelodysplastic Neoplasms
Authors: Zdenek Krejcik, David Kundrat, Monika Belickova, Jiri Klema, Andrea Hrustincova, Iva Trsova, Jaroslav Cermak, Anna Jonasova, Michaela Dostalova Merkerova
Journal: Blood (2024)
CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review
Authors: Luciana Vinti, Jolanda Pianese, Elisa Carraro, Paola Muggeo, Daniela Onofrillo, Irene d'Alba, Elisabetta Schiavello, Raffaella De Santis, Concetta Micalizzi, Veronica Barat, Katia Perruccio, Luca Lo Nigro, Barbara Buldini, Lara Mussolin, Valentina Bertaina, Rita de Vito, Marta Pillon, Franco Locatelli
Journal: Blood (2024)
Prognostic Value of BRAFV600E in Peripheral Blood of Children with Langerhans Cell Histiocytosis: A Multicenter Project of the European Consortium for Histiocytosis
Authors: Linda Beneforti, Paul Milne, Aurora Chinnici, Maria Luisa Coniglio, Sébastien Héritier, Astrid Van Halteren, Caroline Hutter, Irene Trambusti, Francesco Pegoraro, Zofia Hélias-Rodzewicz, Raphaela Schwentner, Natasja Roozeboom, Michele Tanturli, Jean-Francois Emile, Cor Van Den Bos, Milen Minkov, Jean Donadieu, Matthew Collin, Elena Sieni
Journal: Blood (2024)
Outcomes of Venetoclax-Based Treatment Combinations in Relapsed/Refractory Multiple Myeloma: Real-World Practice Patterns and Impact of Cytogenetics on Outcomes
Authors: Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, Nadine Abdallah, P. Leif Bergsagel, Moritz Binder, Francis Buadi, Saurabh Chhabra, Joselle Cook, David Dingli, Angela Dispenzieri, Morie A. Gertz, Wilson I. Gonsalves, Suzanne R Hayman, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, Yi Lin, Eli Muchtar, Ricardo D. Parrondo, Vivek Roy, Taimur Sher, Mustaqeem A. Siddiqui, Rahma M Warsame, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Michelle G. Rogers, Udit Yadav, J E Wiedmeier-Nutor, Dragan Jevremovic, Linda B. Baughn, Vincent Rajkumar, Rafael Fonseca, Sikander Ailawadhi, Shaji Kumar
Journal: Blood (2024)
<i>PTPN11</i> Mutations Are Associated with Shorter Survival in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax
Authors: Vishvaas I Ravikumar, Jessica T. Leonard, Laura F. Newell, Arpita Gandhi, Gabrielle Meyers, Brandon Hayes-Lattin, Richard T. Maziarz, Rachel J. Cook, Elie Traer, Ronan T. Swords, Jennifer N. Saultz, Jeffrey W. Tyner, Mael Heiblig, Joshua F Zeidner, Daniel A Pollyea, Curtis A Lachowiez
Journal: Blood (2024)